Skip to main content
Clinical Trials/NCT06108271
NCT06108271Active, not recruitingNot Applicable

Innovative Endotracheal Tube Design Reduces Postoperative Laryngeal Injury

University Hospital of the Nuestra Señora de Candelaria2 sites in 1 country68 target enrollmentStarted: October 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
68
Locations
2
Primary Endpoint
Laryngeal injury

Study Overview

Brief Summary

The goal of this randomized clinical trial is to compare two different orotracheal tubes in patients which require orotracheal intubation for general anesthesia. The main questions it aims to answer are:

  • To assess the presence of laryngeal injury
  • To evaluate the consequences in voice quality
  • To ask for the presence of symptoms as sore throat, hoarseness, and cough

Participants will be randomly assigned into two groups, one will use conventional endotracheal tube and the other will use Triglotix® endotracheal tube.

Detailed Description

Endotracheal intubation is necessary in some patients undergoing surgical procedures and patients requiring mechanical ventilation in the intensive care unit. However, endotracheal intubation is associated with known complications. In post-surgical patients subjected to orotracheal intubation, the incidence of dysphagia, sore throat, hoarseness and cough is 43%,38%27%,32% respectivelly. These figures increase in cases of prolonged intubation, such as those in intensive care units, where reported rates are 76% for sore throat, 63% for hoarseness and 49% for dysphagia. No significant endotracheal tube design improvements have been developed over the past few decades addressing these issues.

The present study aims to compare the incidence of laryngeal injuries, and related symptoms as sore throat, hoarseness, swallowing problems, bucking and coughing between two defined sample populations: those utilizing a conventional endotracheal tube (ETT-C) and those employing the new Triglotix® endotracheal tube (ETT-T) in patients undergoing elective surgery requiring general anesthesia and mechanical ventilation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Elective perianal surgery requiring intubation for general anesthesia
  • Duration range 30-90 minutes

Exclusion Criteria

  • Difficult airway
  • American Society of Anesthesiologists physical status (ASA) > III
  • Morbid obesity (body mass index >40 kg/m2)
  • Patients not suitable for outpatient surgery
  • Patients with history of previous neck surgery
  • Patients with history of dysphagia
  • Patients with comorbidities as diabetes and hypertension.

Outcomes

Primary Outcomes

Laryngeal injury

Time Frame: Immediately before the induction and 45 minutes after the end of the procedure

Laryngeal pathology was assessed based on the location (unilateral: right/left or bilateral) and on morphology: grade 0 = no lesions, grade 1 = superficial erythema (redness of the mucosa without surrounding inflammation), grade 2 = oedema (swollen mucosa at the vocal cords), grade 3 haematoma (redness of the mucosa with surrounding inflammatory swelling), grade 4 = mucosal laceration (causing active bleeding into the vocal cords), grade 5 = arytenoid dislocation or subluxation (arytenoid with limited movement), and grade 6 = vocal cord palsy

Secondary Outcomes

  • Postoperative cough(45 minutes after the end of the procedure)
  • Bucking during extubation(During extubation)
  • Acoustic Voice Quality Index 03.01 (AVQIv3)(Immediately before the induction and 45 minutes after the end of the procedure)
  • Acoustic Breathiness Index (ABI)(Immediately before the induction and 45 minutes after the end of the procedure)

Investigators

Sponsor
University Hospital of the Nuestra Señora de Candelaria
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Pedro Luis Bravo

Director

University Hospital of the Nuestra Señora de Candelaria

Study Sites (2)

Loading locations...

Similar Trials

Innovative Endotracheal Tube Design... | Clinical Trial